Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Svetlana I. Nihtyanova"'
Autor:
Abeer Ghuman, Dinesh Khanna, Celia J F Lin, Daniel E Furst, Ganesh Raghu, Fernando J Martinez, Mauro Zucchetto, Suiyuan Huang, Angus Jennings, Svetlana I Nihtyanova, Christopher P Denton
Publikováno v:
Rheumatology.
Objectives Explore prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease (SSc-ILD) outcomes in a phase 3 trial (focuSSced) and prognostic markers in a real-world cohort (SMART). Methods The focuSSced SSc-ILD sub
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6d446a3b2fedf6aa165d4f123f55967
https://doi.org/10.1093/rheumatology/kead234
https://doi.org/10.1093/rheumatology/kead234
Autor:
Svetlana I. Nihtyanova, Benjamin E. Schreiber, Voon H. Ong, Athol U. Wells, John G. Coghlan, Christopher P. Denton
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.).
Pulmonary hypertension (PH) is a serious complication of systemic sclerosis (SSc). We explore prediction of short-term risk for PH using serial pulmonary function tests (PFTs) and other disease features.Subjects with SSc, disease onset≥10 years pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::702d07193c0041965d6f1891290a493d
https://pubmed.ncbi.nlm.nih.gov/36122180
https://pubmed.ncbi.nlm.nih.gov/36122180
Autor:
Charles Murray, Rory H Maclean, Fiza Ahmed, Voon H Ong, Christopher P. Denton, Svetlana I. Nihtyanova
Publikováno v:
Rheumatology. 61:781-786
Objectives To assess the prevalence and burden of SSc-related gastrointestinal dysfunction (SSc-GI) and to evaluate associations with demographic, clinical and serological characteristics. Methods Patients completed the UCLA SCTC GIT 2.0 questionnair
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::657c620ac664d3a4b3705762c12bbd3b
https://doi.org/10.1093/rheumatology/keab395
https://doi.org/10.1093/rheumatology/keab395
Publikováno v:
J Scleroderma Relat Disord
Background: Linear morphoea is a severe morphoea subtype associated with extracutaneous manifestations, potentially permanent disfigurement and functional impairment. Linear morphoea is more prevalent in paediatric patients, and knowledge of disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f227156afc3dea2cdfe161d301c3c65
https://doi.org/10.1177/2397198320925684
https://doi.org/10.1177/2397198320925684
Autor:
Emma Derrett-Smith, Christopher P. Denton, Jennifer Harvey, Alper Sari, Voon H Ong, Svetlana I. Nihtyanova, Anna Leslie, Carmen Fonseca
Publikováno v:
Arthritis & Rheumatology. 72:465-476
OBJECTIVE To describe the associations between autoantibodies, clinical presentation, and outcomes among patients with systemic sclerosis (SSc) in order to develop a novel SSc classification scheme that would incorporate both antibodies and the cutan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e5963d8bd738b2bf331ab83c3b444b7
https://doi.org/10.1002/art.41153
https://doi.org/10.1002/art.41153
Autor:
Felix Chua, Christopher P. Denton, Dina Visca, Peter M. George, Cécile Daccord, Elisabetta A. Renzoni, Philip L. Molyneaux, Maria Kokosi, Louise V. Wain, Angelo De Lauretis, Toby M. Maher, David Abraham, Vasilis Kouranos, Athol U. Wells, George Margaritopoulos, Carmel Stock, Svetlana I. Nihtyanova, Voon H Ong
Publikováno v:
Clinical Rheumatology. 39:1173-1179
Although several genetic associations with scleroderma (SSc) are defined, very little is known on genetic susceptibility to SSc-associated interstitial lung disease (SSc-ILD). A number of common polymorphisms have been associated with SSc-ILD, but mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76ff2513fb82182edba24c23556ea44e
https://doi.org/10.1007/s10067-019-04922-6
https://doi.org/10.1007/s10067-019-04922-6
Autor:
Silvia Bellando-Randone, Ulrich A. Walker, Marc Frerix, Svetlana I. Nihtyanova, Veronika Lóránd, Marco Matucci-Cerinic, Ingo H. Tarner, Serena Vettori, Veronika K. Jaeger, Ulf Müller-Ladner, Giuseppina Abignano, Jérôme Avouac, G. Riemekasten, Cosimo Bruni, Oliver Distler, L. Czirják, Yannick Allanore, Alberto Moggi-Pignone, F. Del Galdo, Jelena Blagojevic, Laura Cometi, Dörte Huscher, Christopher P. Denton, Britta Maurer, Serena Guiducci, Elise Siegert
Publikováno v:
Clinical Rheumatology. 39:27-36
DeSScipher is the first European multicentre study on management of systemic sclerosis (SSc), and its observational trial 1 (OT1) evaluated the efficacy of different drugs for digital ulcer (DU) prevention and healing. The aim of this study was to as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5a4d35b4711c713713489c16db856cc
https://doi.org/10.1007/s10067-019-04564-8
https://doi.org/10.1007/s10067-019-04564-8
Autor:
Julia Spierings, Svetlana I. Nihtyanova, Christopher P. Denton, Kristina E N Clark, Jacob M. van Laar, Voon H Ong, Emma Derrett-Smith
Publikováno v:
Rheumatology (Oxford, England). 61(5)
Objectives The aim of this study was to explore outcomes in a cohort of dcSSc patients fulfilling eligibility criteria for stem cell transplantation (SCT) studies but receiving standard immunosuppression. Methods From a large single-centre dcSSc coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b96a2dfdb2270df8149db60e687224d
https://pubmed.ncbi.nlm.nih.gov/34314500
https://pubmed.ncbi.nlm.nih.gov/34314500
Publikováno v:
Rheumatology. 59
Background The FaSScinate and FocuSSced trials of tocilizumab versus placebo in early diffuse systemic sclerosis (SSc) highlighted the potential impact of tocilizumab on lung function with preservation of lung function in those treated with tocilizum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::634d9141243a317800a28926de5557c3
https://doi.org/10.1093/rheumatology/keaa111.148
https://doi.org/10.1093/rheumatology/keaa111.148
Autor:
Svetlana I. Nihtyanova, Voon H Ong, Carmen Fonseca, Emma Derrett-Smith, Christopher P. Denton
Publikováno v:
Rheumatology. 59
Background Skin thickness improves over time in most diffuse cutaneous systemic sclerosis (dcSSc) patients and the use of group level skin score (mRss) as an endpoint is clinical trials can be challenging. We explore the association between individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::767b800f6ece02f748c430b8117c5227
https://doi.org/10.1093/rheumatology/keaa111.147
https://doi.org/10.1093/rheumatology/keaa111.147